Search

everythinglearnresearchcommunity

for

Search:↓

IL-33 is linked to hair follicle damage in psoriasis and could be a treatment target for hair loss in this condition.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

UVA1-light therapy successfully treated a child's skin condition, mycosis fungoides.

People with alopecia areata have similar retinal structures but thicker choroidal regions compared to those without the condition.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

Wound healing is complex and requires more research to enhance treatment methods.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

Early intervention and patient education are crucial for managing alopecia areata.

Innovative methods are reducing animal testing and improving biomedical research.

Different hair growth phases affect how follicles respond to X-rays, and hormones like testosterone and dihydrotestosterone play a key role in baldness; transplanted hair can grow on bald scalp areas.

Lupus affects the skin in various ways, and proper skin examination is crucial for diagnosis and treatment.

Tretinoin gel is safe for sun exposure, but tacalcitol doesn't significantly improve non-segmental vitiligo.

Alopecia areata patients have more activated T cells in their blood, which may help in developing treatments.

Some psychoactive drugs can cause skin reactions, with carbamazepine having a higher risk, and stopping the drug and seeing a dermatologist is important.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Current research explores hair growth drugs, while future research aims for personalized treatments.

Alopecia areata is an autoimmune disease affecting hair follicles and may harm heart health.

Alopecia areata involves immune response and gene changes affecting hair loss.

To treat tinea capitis in children, oral antifungal medication is necessary, with newer drugs offering shorter treatment times than the traditional griseofulvin.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

CAR-T therapy offers hope for children with hard-to-treat blood cancers.

Vitamin D compounds may help treat psoriasis by promoting skin cell differentiation.

Natural products like propolis are causing more skin allergies, and certain skin treatments and medications have various side effects and risks.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

No cure exists for alopecia areata, and treatments are personalized.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

3D spheroid culture makes stem cells better at reducing inflammation.